Related references
Note: Only part of the references are listed.Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism
Isabella Lupi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research
Douglas B Johnson et al.
LANCET ONCOLOGY (2020)
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Lee-Shing Chang et al.
ENDOCRINE REVIEWS (2019)
French Endocrine Society Guidance on endocrine side effects of immunotherapy
F. Castinetti et al.
ENDOCRINE-RELATED CANCER (2019)
The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid Disorders
Chanjuan Ma et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
Biagio Ricciuti et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
National Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and Without Thyroid Storm in the United States, 2004-2013
Rodolfo J. Galindo et al.
THYROID (2019)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Effect of Thyroglobulin Autoantibodies on the Metabolic Clearance of Serum Thyroglobulin
Francesco Latrofa et al.
THYROID (2018)
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C. Arbour et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction
Luigi Bartalena et al.
EUROPEAN THYROID JOURNAL (2018)
Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSH
Mads Lillevang-Johansen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma
D. L. Morganstein et al.
CLINICAL ENDOCRINOLOGY (2017)
Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With Pembrolizumab
Jeroen de Filette et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
Douglas S. Ross et al.
THYROID (2016)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Clinical characteristics of 852 patients with subacute thyroiditis before treatment
Eijun Nishihara et al.
INTERNAL MEDICINE (2008)
Non-palpable thyroid nodules in a borderline iodine-sufficient area: Detection by ultrasonography and follow-up
T Rago et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2001)
Share Paper
